Vivendy Therapeutics
Latest round
- Series A
Last raised
- Jun 2008
Total raised
- $30M
Investors
- 4
About Vivendy Therapeutics
Vivendy Therapeutics is a Switzerland-based company that operates as a developer of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency.
Who invested in Vivendy Therapeutics
4 investors across 2 rounds
See all investors in Vivendy Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vivendy Therapeutics
Who invested in Vivendy Therapeutics?
Vivendy Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vivendy Therapeutics raised?
Vivendy Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vivendy Therapeutics last raise money?
Vivendy Therapeutics's most recent round on record is a Series A, in Jun 2008.
What does Vivendy Therapeutics do?
Vivendy Therapeutics is a Switzerland-based company that operates as a developer of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency.
Where is Vivendy Therapeutics headquartered?
Vivendy Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Vivendy Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Vivendy Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vivendy Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.